Le Lézard
Classified in: Health, Science and technology
Subject: PER

NJII Names New Chief Operating Officer and Executive Vice President of Healthcare Division


New Jersey Innovation Institute (NJII) has appointed?Jennifer D'Angelo as the Chief Operating Officer and the Executive Vice President of its Healthcare Division.

NEWARK, N.J., April 25, 2024 /PRNewswire-PRWeb/ -- Through its 2030 Strategic Plan, NJII plans to double the size of the organization and to exceed $70M revenue as it rolls out various new initiatives focused on accelerating technology translation, spurring innovation and upskilling workers. As NJII's COO, Jennifer will play a key leadership role in shaping the organization and leading strategic growth initiatives.

Jennifer adds, "This role presents a unique opportunity to leverage my background in healthcare technology and management to significantly advance our mission and impact across the industry."

"I look forward to working closely with Jennifer as we align operational objectives to our mission and vision.? Jennifer's leadership and expertise will continue to direct the Healthcare division on its growth trajectory, and now Jennifer will have the opportunity to impact operational alignment across NJII," said NJII President?Michael Johnson, Ph.D.?

For the last 4 years, Jennifer has been leading the Healthcare division at NJII as the Senior Vice President and General Manager.? Her oversight of the division as the Executive Vice President will be crucial to the continued growth and sustainability of programs.?

With over two decades of CIO and General Manager experience, Jennifer is an innovative leader in the healthcare industry, where she has dedicated her career to leveraging technology, innovation, and strategic leadership to revolutionize healthcare delivery and patient care.? Her experience includes positions within healthcare providing facilities in New Jersey where she led digital transformation efforts to ensure a seamless and efficient patient care experience.???

"I am honored to step into this new role as the Chief Operating Officer at NJII. I am excited to lead our operational strategy to meet the ambitious objectives of our 2030 Strategic Plan. My focus will be on streamlining our processes and enhancing our organizational capabilities to not only achieve, but exceed, our goal of doubling the size of NJII and surpassing $70 million in revenue. This role presents a unique opportunity to leverage my background in healthcare technology and management to significantly advance our mission and impact across the industry."

D'Angelo earned her Bachelor of Science in Business Administration (BSBA) from Thomas Edison State University and her Master of Science in Healthcare Management (MSHCM), Health/Healthcare Administration/Management from Thomas Edison State University.? Jennifer is active in volunteering within the industry on several committees and boards.? She often speaks and presents at major healthcare conferences such as HIMSS, NJHIMSS and NJAMHAA. She has been recognized as Top 50 Women We Admire of NJ, CIANJ Enterprising Women in Commerce, CIO Views Magazine, and NJBIZ Healthcare Hero and Leader in Digital Technology.

To learn more about?Jennifer D'Angelo and the rest of NJII's leadership team, click here.

Media Contact

Victoria McMullen, NJII, 8632274557, [email protected], njii.com

Twitter

SOURCE NJII


These press releases may also interest you

at 15:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: